文献速递慢阻肺

COPD与2型糖尿病对骨骼健康的比较及叠加风险评估:全国倾向性评分匹配队列研究

COPD vs Type 2 Diabetes Mellitus: A Comparative and Additive Risk Assessment of Bone Health in a Nationwide Propensity Score-Matched Cohort.
PubMed 文献 · Chest · 2026-09-21

该研究利用台湾全民健康保险研究数据库构建倾向性评分匹配队列,比较COPD、T2DM及两者共存患者发生骨质疏松和骨折的风险。结果显示COPD对骨骼的危害显著高于T2DM,两者共存时骨折风险较单纯T2DM进一步增加,且COPD与骨质疏松的关联在男性中更强。

要点

  • COPD患者骨质疏松风险显著高于T2DM患者(aHR 1.51)。
  • COPD合并T2DM较单纯T2DM增加主要骨质疏松性骨折和脊柱骨折风险。
  • 男性COPD患者是疾病相关骨丢失的显著易感人群。

核心结论

  • COPD对骨骼的危害显著大于T2DM,两者共存较单纯T2DM进一步增加骨折易感性。
  • 男性COPD患者对疾病所致骨丢失尤为易感,应优先进行骨质疏松筛查。

研究设计与样本

  • 基于台湾全民健康保险研究数据库的全国性回顾性队列研究。
  • 采用倾向性评分匹配构建T2DM、COPD及COPD合并T2DM三个比较队列。
  • 使用多变量Cox比例风险模型估计骨质疏松、主要骨质疏松性骨折及部位特异性骨折的调整风险比。

主要发现

  • 与T2DM相比,COPD与更高的骨质疏松风险相关(aHR 1.51;95% CI 1.35-1.69)。
  • COPD合并T2DM较单纯T2DM的骨质疏松风险更高(aHR 1.39;95% CI 1.23-1.57)。
  • COPD合并T2DM较单纯T2DM的主要骨质疏松性骨折风险更高(aHR 1.19;95% CI 1.08-1.32)。
  • COPD合并T2DM较单纯T2DM的脊柱骨折风险更高(aHR 1.35;95% CI 1.16-1.58),桡尺骨骨折风险亦更高(aHR 1.21;95% CI 1.02-1.43)。
  • COPD合并T2DM与单纯COPD之间的骨质疏松和骨折风险相当。

临床怎么用

  • 临床应优先对COPD患者(尤其是男性)进行早期、针对性的骨质疏松筛查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: COPD and type 2 diabetes mellitus (T2DM) are both associated with bone fragility through distinct mechanisms. COPD is characterized by accelerated bone resorption, whereas T2DM is associated with impaired bone quality despite preserved bone mineral density. RESEARCH QUESTION: Does COPD confer greater skeletal hazards than T2DM, and does concomitant COPD and T2DM further increase the risks of osteoporosis and fractures? STUDY DESIGN AND METHODS: We conducted a nationwide retrospective cohort study using Taiwan's National Health Insurance Research Database. Propensity score matching was applied to construct 3 comparison cohorts of patients with T2DM, COPD, and concomitant COPD and T2DM. Adjusted hazard ratios (aHRs) for incident osteoporosis, major osteoporotic fractures, and site-specific fractures were estimated using multivariable Cox proportional hazards models after adjustment for demographic characteristics, comorbidities, and medication use. RESULTS: Compared with T2DM, COPD was associated with a significantly higher hazard of osteoporosis (aHR, 1.51; 95% CI, 1.35-1.69). Patients with concomitant COPD and T2DM also had higher hazards of osteoporosis (aHR, 1.39; 95% CI, 1.23-1.57), major osteoporotic fractures (aHR, 1.19; 95% CI, 1.08-1.32), spine fractures (aHR, 1.35; 95% CI, 1.16-1.58), and radioulnar fractures (aHR, 1.21; 95% CI, 1.02-1.43) than patients with T2DM alone. In contrast, osteoporosis and fracture risks were comparable between patients with concomitant COPD and T2DM and those with COPD alone. Subgroup analyses identified significant effect modification by sex, with the association between COPD and osteoporosis being stronger in male patients than in female patients. INTERPRETATION: Our results show that COPD is significantly more toxic to the skeleton than T2DM, and their coexistence amplifies fracture susceptibility compared with T2DM alone. Importantly, male patients with COPD represent a distinctly vulnerable population, exhibiting a pronounced susceptibility to disease-induced bone loss. Clinicians must prioritize early and targeted osteoporosis screening for patients with COPD, especially men.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Ko FS, Wei JC, Yen FS, et al. COPD vs Type 2 Diabetes Mellitus: A Comparative and Additive Risk Assessment of Bone Health in a Nationwide Propensity Score-Matched Cohort. Chest. 2026. PMID: 42767594. doi:10.1016/j.chest.2026.09.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。